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Material and methods 
Induction of permanent focal cerebral ischemia and volume of the 
infarct 
 We performed permanent MCAO in IL10T (n = 6) and WT (n=6) mice. 
Animals were anaesthetized intraperitoneally with xylazine (20 mg/kg) / 
ketamine (100 mg/kg) in 0.9% NaCl (100 l/10g body weight), the right 
temporoparietal region of the head was shaved and a 2-mm incision was 
made vertically between the orbit and the ear and the skull exposed. 
Using a high-speed microdrill, a small burr hole of 1 mm
2
 was made 
through the outer surface of the semitranslucent skull under an operating 
microscope. This was located just above the visibly identified medial 
cerebral artery at the level of the parietal cerebral artery. Saline was 
applied to the area throughout the procedure to prevent heat injury. The 
inner layer of the skull was removed with a fine forceps, the dura and the 
arachnoid were opened and right permanent MCAO was performed by 
electrocoagulation (by means of a small-vessel cauterizer) without 
damaging the brain surface. If the brain surface was visibly damaged or if 
the middle cerebral artery bled owing to incomplete artery 
occlusion/coagulation, the animal was not used for the study. The 
duration of the surgery did not exceed 15 min in any case (de Bilbao et al. 
2004). Permanent inhibition of cerebral blood flow after the lesion was 
assessed by visual inspection and by transcranial measurements of CBF 
that were made using laser Doppler flowmetry Oxford Optronix Ltd (UK) 
just before and after MCAO. Animals were placed under a sterotactic 
head frame and then a fine needle probe (MNP110XP, 0.48 mm 
diameter) was lowered onto the temporal bone surface 0.5 to 1 mm dorsal 
to the opening giving access to the MCA and wetted with a small amount 
of physiological saline.  
Four days later, the animals were perfused through the ascending 
aorta with a solution of paraformaldehyde 4% in phosphate-buffered 
saline (PBS, pH 7.35). Brains were removed and processed for paraffin 
embedding. Sections (7 m) of the whole infarct area were cut with a 
microtome and collected on slides pretreated with 3-
aminopropyltriethoxy-silane (Sigma, Buchs, Saint Gallen, Switzerland). 
Sections were counter-stained with cresyl-violet for the histological 
identification of the nuclear boundaries and peri-infarct areas and 
mounted in Eukitt. For each animal, quantification of the infarcted area 
was performed on the cresyl-violet stained sections at five representative 
levels throughout the rostro-caudal extent of the lesion (A 0.26, -0.22, -
0.40, -0.70 and -1.2 -4mm relative to Bregma) (Franklin and Paxinos 
1997). The rostro-caudal extent of the infarct was the same in both groups 
of mice. The infarcted area of each section was calculated by the 
substraction of healthy tissue areas of the contralateral to the ipsilateral 
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side of the section in order to compensate for the effect of brain edema 
(Guegan et al. 1998) using a computer-assisted image analyzing system 
(Software «Morphometry», Samba 2005 TITN, Alcatel). Infarct volumes 
(mm
3
) were calculated for each animal after integration of areas with the 
distance between each level (de Bilbao et al. 2004). 
To evaluate whether local alterations in cerebral vasculature 
anatomy contribute to different susceptibility to injury, an additional 
series of WT and IL10T mice (n=5 for each group) were killed on days 1 
and 4 after ischemia. Cerebral vasculature was studied in non-operated 
and operated mice after intracardial perfusion of a mixture of equal 
proportion of gelatinous water (5%) and China ink (Sennelier, France) 
warmed at 40°C (1 ml). Then brains were removed and immersed for 24 
hrs in 4% paraformaldehyde at 4°C (Chen et al. 2005). The cerebral 
vasculature was observed with a Zeiss stereo zoom microscope.  
 
Physiological parameters for MCAO study 
Physiological parameters including arterial blood pressure (Kent mouse 
tail blood pressure system RTBP2000, Kent Scientific Corporation, 
Torrington, USA), plasma glucose (using Roche Glucotrend Active, 
Rotkreuz, Switzerland) and hematocrit were measured daily in IL10T and 
WT mice (n=5) before MCAO and on days 1 and 4 post-injury. Body 
temperature was measured prior to MCAO, during and following MCAO 
by a rectal thermometer probe (Ellab DM 852, Roeovre, Denmark). 
During surgery, mice were placed on a warm mat and rectal temperature 
was measured. In the operation period rectal temperature was similar in 
WT (38.0 ± 0.1 °C) and IL10T (38.0 ± 0.1 °C) mice and remained stable 
after the operation. After the operation, mice were placed in their cage 
with a heating lamp to maintain body temperature at 38°C up to 3 hours 
after they woke up and were moving around. Daily body temperature was 
measured at 10:30 am. 
 
Western blot procedure for glucose transporters Glut1 and Glut4 
and Glucose-6-phophate dehydrogenase enzyme activity  
Hemispheres from non-operated WT and IL10T mice were used (n=4 for 
each groups). Hemispheres were homogenized in solubilization buffer at 
4°C (120 mM NaCl, 50 mM Tris [pH 8.0], 20 mM NaF, 1 mM 
benzamidine, 1 mM EDTA, 1 mM EGTA, 1 mM sodium pyrophosphate, 
30 mM 4-nitrophenylphosphate disodium salt hexahydrate, 1% NP-40, 
and 0.1 M phenylmethylsulfonylfluoride [PMSF]) with a Polytron 
homogenizer. The homogenate was centrifuged and the supernatant was 
collected and stored at -20C prior to blotting. Protein content of the 
supernatants was determined by Bradford (Bio-Rad, Reinbach, Basel, 
Switzerland). Gel electrophoresis was carried out at 40 micrograms per 
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sample. Proteins were transferred on to an immobilon-P membrane 
(Millipore, Zug, Zug, Switzerland). Membranes were then incubated 
overnight with primary antibody (goat anti-Glut1 (sc1605) (1/200) or 
goat anti-Glut4 (sc1608) (1/200) from Santa Cruz, CA, US; mouse Anti-
tubulin (1/25000), Sigma, Buchs, Saint Gallen, Switzerland). Secondary 
antibodies Licor anti-mouse for tubulin (1/1000) and Licor anti-goat 
(1/1000) were used to detect bands (Li-Cor Biosciences, Bad Homburg, 
Germany). The signals were visualized with the use of the Odyssey 
Infrared Imaging System (LI-COR Biosciences). Quantification of the 
signals was performed with the use of Odyssey Application Software 1.2. 
Protein levels were expressed as the ratio against tubulin (Viswambharan 
et al. 2007).  
The enzyme glucose-6-phosphate dehydrogenase (G6PDH) was 
also studied since it play a key role in glucose metabolism and redox 
regulation via the pentose phosphate pathway (Spolarics 1998). 
Hemispheres from non-operated WT and IL10T mice were used (n=4 for 
each groups). They were homogenized with polytron homogenizer in a 
solution containing 0.2M Tris buffer (pH7.0) kept on ice. After 
centrifugation at 8,500 g, the supernatant was collected and kept at -20C 
prior to assay for G6PDH activity. Fifteen l of extract containing 
1mg/ml of protein as determined by Bradford (Bio-Rad, Reinbach, Basel, 
Switzerland) was added to 100 l buffer containing 0.2M Tris (pH7.0) 
and NADP+ (10mg / ml). To start the reaction, 50 l of G6P (0.3g in 
1ml) was added to the previous mentioned solution. The activity was 
determined by measuring the change in OD at 340 nm during 15 minutes.  
 
Western blot procedure for caspase-3  
Ischemic hemispheres from lesioned WT and IL10T mice were used (n=6 
for each groups). The equivalent hemisphere was used in control non-
ischemic mice. Hemispheres were homogenized in solubilization buffer 
at 4°C as described above (see Western blot procedure for glucose 
transporters). Membranes were incubated overnight with primary 
antibody (rabbit Anti-caspase-3 (sc1605) at 1/1000 from Santa Cruz, CA, 
US; mouse Anti-tubulin at 1/25000 from Sigma, Buchs Saint Gallen, 
Switzerland). Secondary antibodies Li-Cor anti-mouse for tubulin 
(1/1000) and Alexa Fluor anti-rabbit for caspase-3 (1/1000) from Li-Cor 
Bad Homburg, Germany, were used to detect bands. 
 
Lipid peroxidation in brain homogenates 
We performed measures of malondialdehydes (MDA), an indicator of 
endogenous lipid peroxidation, on days 1 and 4 after MCAO in WT and 
IL10T mice (n=5 for each group). Mice were anesthetized and perfused 
intracardially with a NaCl (9
0
/0) solution. After perfusion, brains were 
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removed and washed 3 times in ice-cold Tris-HCl 20 mM buffer (pH 
7.4). Tissues from the ischemic hemispheres of operated animals and 
equivalent hemisphere of control non-operated animals were 
homogenized to give a 30% solution (ie 300 mg of tissue in 1 ml of 
buffer) in 20 mM Tris buffer pH 7.4. To measure lipid peroxidation, the 
Biotech LPO-586 colorimetric assay kit and its protocol (Oxis, Portland, 
USA) was used. In order to prevent sample oxidation 0.5 mM butylated 
hydroxytoluene (BHT, Sigma – Buchs, Saint Gallen, Switzerland) was 
added to the tissue homogenates. Subsequently samples were centrifuged 
at 4 C to remove cellular debris. Aliquots were then taken for 
determination of MDA using the methanesulfonic acid solvent procedure 
(de Bilbao et al. 2004). Optical density readings were made at 586 nm 
using a microplate reader (DynaTech MR5000) and corrections were 
made for sample and reagent blanks. Concentrations were then 
determined using a standard curve. Non-operated mice were used as 
controls (n=5 for each group). 
 
Brain superoxide dismutase activity one day after MCAO 
We investigated SOD activity in the ischemic hemispheres of IL10T and 
WT mice subjected to ischemia (one day post-MCAO) (n=6 mice per 
group) using a biochemical assay (Ewing and Janero 1995). The 
equivalent hemisphere was used in control non-operated animals. 
Hemispheres were homogenised in phosphate buffered saline and frozen 
immediately in liquid nitrogen. Aliquots of tissue supernatants were 
processed as previously described (Ewing and Janero 1995). Briefly, 
tissue aliquots were added (25 l) to a 125 l solution containing 50 mM 
phosphate buffer (pH 7.4, 0.1 mM EDTA, 50 M NBT, 78 M NADH). 
To start the reaction, 25 l of 3.3 M PMS phenazine methosulfate (final 
concentration) was added and the absorbance at 560 nm was measured 
continuously using a microplate reader (DynaTech MR5000). The 
readings were made every minute for 10 minutes. The first 5 minutes 
were used to determine the rate of superoxide production by the samples.  
 
Brain glutathione levels 
Ischemic hemispheres of operated animals and the equivalent hemisphere 
for control non-operated animals were homogenised in phosphate buffer 
(50 mM, pH 7.4). Total GSH levels were measured using a method based 
on the formation of a chromophoric product resulting from the reaction of 
5,5’-dithiobis-(2-nitrobenzoic acid) (DTNB, Sigma, Buchs, Saint Gallen, 
Switzerland) and GSH (Sigma, Buchs, Saint Gallen),  (de Bilbao et al. 
2004). The absorbance was immediately measured at 412 nm. 
Glutathione contents were calculated by using a calibration curve 
established with standard samples. Brain GSH levels were measured 1 
  5 
and 4 days after the lesion (n=4 for each group). Non-operated mice were 
used as controls (n=4 for each group). 
 
Determination of brain cytokine levels  
In order to determine if IL10T had altered cytokine production in 
response to MCAO treatment, we measured TNF , IFN , IL1 , IL10 and 
NGF in the brain ischemic hemispheres of WT and IL10T mice subjected 
to ischemia (n=4 for each group). The equivalent hemisphere was used in 
control non-operated animals. Brain hemispheres of WT and IL10T mice 
were collected one day after the operation. 100 mg of tissue were 
homogenized with 600 l of 1% CHAPS (3-[(3-
cholamidopropyl)dimethylammonio]-1-propanesulfonate) in RPMI-
1640 medium without Phenol red (R7509, Gibco) with a polytron 
homogenizer (Nakane et al., 1992). The supernatant was collected and 
frozen at -20 C (Arsenijevic et al. 2006). TNF , IFN , IL1 , IL10 and 
NGF were measured using immunoassay kits (Amersham (GE 
Healthcare, Otelingen, Zurich, Switzerland) for the four former and 
Promega, Dubendorf, Zurich, Switzerland for NGF) as described 
previously (Arsenijevic et al. 2006). Non-operated mice were used as 
controls (n=4 for each group). 
 
Enzyme immunoassay for neuropeptide Y (NPY), orexin-A and 
melanin-concentrating hormone (MCH) 
 Hypothalami were dissected out in WT and IL10T mice one day after 
MCAO (n=5) and were treated as previously described (Gallmann et al. 
2006). Tissues homogenates were left on ice for 1 h. Brain tissue proteins 
were extracted using 1% (w/v) 3-((3-cholamidopropyl) 
dimethylammonio)-1-propanesulfate (CHAPS, Pierce Biotechnology, 
Rockford IL, USA) (for method see cytokine extraction section). Extracts 
were stored at -80°C until peptide assays. Orexin-A, MCH and NPY were 
quantified by enzyme immunoassay (PhoenixPeptide, Belmont, 
California USA) (Gallmann et al. 2006). Non-operated mice were used as 
controls (n=5). 
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